Radiation With Concomitant and Then Sequential Temozolomide in Malignant Glioma

Clinical trial NCT00283543 · UNKNOWN

Trial details

NCT number: NCT00283543
Sponsor: Kentuckiana Cancer Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Newly Diagnosed Supratentorial Malignant Glioma

Start date: 2002-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.